Healthcare
Inspire Medical Systems, Inc.(INSP)
Live Price
Offline$42.61
+3.62% today
1Y Change
-67.72%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $1.62B
- Revenue Growth
- +13.6%
- EPS Growth
- +175.0%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Inspire Medical Systems, Inc. (INSP) is a Healthcare stock with a market cap of $1.62B and listed on NYSE. The stock last traded around $42.61 and down 67.7% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +13.6%, EPS growth of +175.0%, a dividend yield of 0.0%. What stands out right now is revenue +13.6%, EPS +175.0%, free cash flow -13.9% with operating margin 5.6% and ROIC 6.2%. Valuation is more restrained than many high-expectation growth names at P/E 11.2 and price/sales 1.8. Stock Foundry combines INSP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.6% vs +7.6% peer median
Operating Margin
Below sector median
+5.6% vs +19.4% peer median
P/E
Below sector median
11.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 4, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.6% and EPS at +175.0%, with operating margin around 5.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -5.5% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 4, 2026 | โ | -12.0% | -21.0% | -26.0% |
2026 Feb 11, 2026 | +139.1% | -12.5% | -12.4% | -14.6% |
2025 Nov 3, 2025 | +353.3% | +15.3% | +16.8% | +81.7% |
Benchmark Edge
INSP vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
INSP
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
INSP Max Drawdown
-72.19%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for INSP and SPY.
Company Overview
Inspire Medical Systems, Inc.
New York Stock Exchange
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
- Leadership
- Timothy Herbert
- IPO Date
- May 3, 2018
- Employees
- 1.2k
- Street Address
- 5500 Wayzata Boulevard
- Mailing
- Golden Valley, MN, 55416
- Region
- Golden Valley, MN, US
- Reporting Currency
- USD
- Investor Line
- 844 672 4357
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 11.2
- EV/EBITDA
- 22.5
- Price/Sales
- 1.8
- Price/Book
- 2.1
Growth
- Revenue
- +13.6%
- EPS
- +175.0%
- Free Cash Flow
- -13.9%
Profitability
- Gross Margin
- 85.4%
- Operating Margin
- 5.6%
- Net Margin
- 15.9%
- ROE
- 21.1%
- ROIC
- 6.2%
Balance Sheet
- Debt/Equity
- 0.08
- Current Ratio
- 6.08
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.